In vivo evaluation of magnetite nanoparticles for use as a tumor contrast agent in MRI
- 31 December 1996
- journal article
- Published by Elsevier BV in Magnetic Resonance Imaging
- Vol. 14 (4), 391-402
- https://doi.org/10.1016/0730-725x(95)02106-4
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Biodegradable Long-Circulating Polymeric NanospheresScience, 1994
- Mion-ASF: Biokinetics of an MR receptor agentMagnetic Resonance Imaging, 1993
- Antibody-magnetite nanoparticles: In vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imagingBioconjugate Chemistry, 1993
- Effect of chemically modified GM1 and neoglycolipid analogs of GM1 on liposome circulation time: evidence supporting the dysopsonin hypothesisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particlesMagnetic Resonance in Medicine, 1993
- Iron oxides as MR imaging contrast agentsJournal of Magnetic Resonance Imaging, 1993
- Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivoFEBS Letters, 1991
- Complement-dependent phagocytosis of liposomes by macrophages: Suppressive effects of “stealth” lipidsBiochemical and Biophysical Research Communications, 1991
- Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomesFEBS Letters, 1990
- Antigen- versus antibody-immobilized ELISA procedures based on a biotinyl-estradiol conjugateJournal of Steroid Biochemistry, 1989